Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS)

Status:Active, not recruiting
Therapuetic Areas:Cardiology / Vascular Diseases
Age Range:18 - 80
Start Date:October 2009
End Date:December 2019

Use our guide to learn which trials are right for you!

Assessment of Inspiratory Breathing Devices to Improve Orthostatic Tolerance in Postural Orthostatic Tachycardia Syndrome

The investigators will test whether breathing through an inspiratory resistance device will
improve the ability to be upright and decrease heart rate increases on standing in patients
with postural tachycardia syndrome.

Chronic orthostatic intolerance, sometimes known as the postural tachycardia syndrome (POTS),
is the most common disorder among patients seen at several centers specializing in diseases
of the autonomic nervous system. It affects an estimated 500,000 people in the United States
alone. POTS (excessive increase in heart rate [>30 min-1] on standing associated with
orthostatic symptoms [including palpitation, chest pain syndrome, dyspnea on standing, mental
clouding and difficulties with concentration], in the absence of orthostatic hypotension) can
produce substantial disability among otherwise healthy people. Patients with POTS typically
feel tired and run down. Many also report a myriad of symptoms that are hard to categorize,
often involving fatigue. One study, from the Mayo Clinic, found that patients with POTS had a
diminished quality of life when measured using a standard health status instrument (SF-36).

In this pilot study, we will test the hypothesis that breathing through an inspiratory
resistance device will improve orthostatic tolerance and reduce orthostatic tachycardia in
patients with postural tachycardia syndrome.

Inclusion Criteria:

- Diagnosed with postural tachycardia syndrome by the Vanderbilt Autonomic Dysfunction

- Increase in heart rate ≥ 30 beats/min with position change from supine to standing (10

- Chronic symptoms consistent with POTS that are worse when upright and get better with

- Able and willing to provide informed consent

Exclusion Criteria:

- Overt cause for postural tachycardia (such as acute dehydration)

- Inability to give, or withdrawal of, informed consent

- Pregnant

- Other factors which in the investigator's opinion would prevent the subject from
completing the protocol
We found this trial at
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Principal Investigator: Satish R Raj, MD MSCI
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Nashville, TN
Click here to add this to my saved trials